Literature DB >> 24770928

The influence of hospital drug formulary policies on the prescribing patterns of proton pump inhibitors in primary care.

Michael Due Larsen1, Mette Schou, Anja Sparre Kristiansen, Jesper Hallas.   

Abstract

AIM: This study had two aims: Firstly, to describe how prescriptions for proton pump inhibitor (PPI) in primary care were influenced by a change of the hospital drug policy, and secondly, to describe if a large discount on an expensive PPI (esomeprazole) to a hospital would influence prescribing patterns after discharge.
METHODS: This register study was conducted at Odense University Hospital, Denmark, and by use of pharmacy dispensing data and a hospital-based pharmacoepidemiological database, the medication regimens of patients were followed across hospitalisation. The influence of hospital drug policy on prescribings in primary care was measured by the likelihood of having a high-cost PPI prescribed before and after change of drug policy.
RESULTS: In total, 9,341 hospital stays in 2009 and 2010 were included. The probability of a patient to be prescribed an expensive PPI after discharge decreased from 33.5 to 9.4%, corresponding to a risk ratio of 0.28. In primary care after discharge, 13.4% of esomeprazole use was initiated in the hospital, and this was 8.4% for PPIs in general. After the change of hospital drug policy, this decreased to 6.5% for esomeprazole and increased for the recommended PPIs pantoprazole and lansoprazole to 14.6 and 26.1%, respectively. The effect of a large discount on expensive PPI to hospital was 14.7%, and this decreased to 2.6% when coordinating drug policy in hospital and primary care.
CONCLUSION: The likelihood of having an expensive PPI prescribed after hospital stay decreased when coordinating drug policy and the influence of a large discount to hospital could be minimised.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24770928     DOI: 10.1007/s00228-014-1681-2

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  26 in total

1.  Prescribing new drugs: qualitative study of influences on consultants and general practitioners.

Authors:  M I Jones; S M Greenfield; C P Bradley
Journal:  BMJ       Date:  2001-08-18

2.  Proton pump inhibitors: a study of GPs' prescribing.

Authors:  M I Jones; S M Greenfield; S Jowett; C P Bradley; R Seal
Journal:  Fam Pract       Date:  2001-06       Impact factor: 2.267

Review 3.  Local formularies.

Authors:  D John M Reynolds; Olubunmi Fajemisin; Sara Wilds
Journal:  Br J Clin Pharmacol       Date:  2012-10       Impact factor: 4.335

4.  Comparing policies to enhance prescribing efficiency in Europe through increasing generic utilization: changes seen and global implications.

Authors:  Brian Godman; William Shrank; Morten Andersen; Christian Berg; Iain Bishop; Thomas Burkhardt; Kristina Garuoliene; Harald Herholz; Roberta Joppi; Marija Kalaba; Ott Laius; Diane McGinn; Vita Samaluk; Catherine Sermet; Ulrich Schwabe; Inês Teixeira; Lesley Tilson; F Cankat Tulunay; Vera Vlahović-Palčevski; Kamila Wendykowska; Björn Wettermark; Corinne Zara; Lars L Gustafsson
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2010-12       Impact factor: 2.217

5.  Guidelines for therapeutic interchange-2004.

Authors:  Thomas Gray; Karen Bertch; Kimberly Galt; Michael Gonyeau; Emilie Karpiuk; Lance Oyen; Mary Jane Sudekum; Lee C Vermeulen
Journal:  Pharmacotherapy       Date:  2005-11       Impact factor: 4.705

6.  Soft regulations in pharmaceutical policy making: an overview of current approaches and their consequences.

Authors:  Björn Wettermark; Brian Godman; Bengt Jacobsson; Flora M Haaijer-Ruskamp
Journal:  Appl Health Econ Health Policy       Date:  2009       Impact factor: 2.561

7.  The Danish prescription registries.

Authors:  D Gaist; H T Sørensen; J Hallas
Journal:  Dan Med Bull       Date:  1997-09

8.  The Danish Civil Registration System.

Authors:  Carsten Bøcker Pedersen
Journal:  Scand J Public Health       Date:  2011-07       Impact factor: 3.021

9.  Changes in drug treatment after discharge from hospital in geriatric patients.

Authors:  R A Cochrane; A R Mandal; M Ledger-Scott; R Walker
Journal:  BMJ       Date:  1992-09-19

10.  Influences on GPs' decision to prescribe new drugs-the importance of who says what.

Authors:  Helen Prosser; Solomon Almond; Tom Walley
Journal:  Fam Pract       Date:  2003-02       Impact factor: 2.267

View more
  6 in total

1.  The use of proton pump inhibitors in an Italian hospital: focus on oncologic and critical non-ICU patients.

Authors:  Maria Meli; Maria Pia Raffa; Renato Malta; Ilaria Morreale; Luigi Aprea; Natale D'Alessandro
Journal:  Int J Clin Pharm       Date:  2015-08-30

2.  Use of Proton Pump Inhibitors in Hungary: Mixed-Method Study to Reveal Scale and Characteristics.

Authors:  Mária Matuz; Ria Benkő; Zsófia Engi; Krisztina Schváb; Péter Doró; Réka Viola; Mária Szabó; Gyöngyvér Soós
Journal:  Front Pharmacol       Date:  2020-09-08       Impact factor: 5.810

3.  Value-based Pricing for Rifaximin Increases Access of Patients With Irritable Bowel Syndrome With Diarrhea to Therapy.

Authors:  Eric D Shah; Sameer D Saini; William D Chey
Journal:  Clin Gastroenterol Hepatol       Date:  2019-03-01       Impact factor: 11.382

4.  Hospital-Level Variation in Ticagrelor Use in Patients With Acute Coronary Syndrome.

Authors:  Aya F Ozaki; Cynthia A Jackevicius; Alice Chong; Maneesh Sud; Jiming Fang; Peter C Austin; Dennis T Ko
Journal:  J Am Heart Assoc       Date:  2022-06-29       Impact factor: 6.106

5.  The impact of pharmaceutical interventions on the rational use of proton pump inhibitors in a Chinese hospital.

Authors:  Chuanwei Xin; Zhu Dong; Mengmeng Lin; Gong-Hua Li
Journal:  Patient Prefer Adherence       Date:  2017-12-27       Impact factor: 2.711

6.  Impact of a change of bronchodilator medications in a hospital drug formulary on intra- and out-of-hospital drug prescriptions: interrupted time series design with comparison group.

Authors:  Raquel Vázquez-Mourelle; Eduardo Carracedo-Martínez; Adolfo Figueiras
Journal:  Implement Sci       Date:  2020-05-14       Impact factor: 7.327

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.